logo-loader
OTCMKTS:PPCB

Propanc Biopharma Inc

Receive alerts
Market:
OTCMKTS
Market Cap:
$1.22 m
Price
$1.45
Change
3.57%
52 weeks high
144.40
52 weeks low
0.06

In brief

Propanc Biopharma, Inc. is a clinical stage biopharmaceutical company focused on developing new cancer treatments for patients suffering from pancreatic, ovarian and colorectal cancers. Together with our scientific and oncology consultants, we have developed a novel therapeutic approach based on 100 years of the scientific study of enzyme use. Our leading products not only treat metastatic cancer but reduce recurrence.